Your browser doesn't support javascript.
loading
Model for regional collaboration: Successful strategy to implement a pediatric early warning system in 36 pediatric oncology centers in Latin America.
Agulnik, Asya; Gonzalez Ruiz, Alejandra; Muniz-Talavera, Hilmarie; Carrillo, Angela K; Cárdenas, Adolfo; Puerto-Torres, Maria F; Garza, Marcela; Conde, Tania; Soberanis Vasquez, Dora J; Méndez Aceituno, Alejandra; Acuña Aguirre, Carlos; Alfonso, Yvania; Álvarez Arellano, Shillel Yahamy; Argüello Vargas, Deiby; Batista, Rosario; Blasco Arriaga, Erika Esther; Chávez Rios, Mayra; Cuencio Rodríguez, María Elena; Fing Soto, Ever Amilcar; Gómez-García, Wendy; Guillén Villatoro, Rafael H; Gutiérrez Rivera, María de Lourdes; Herrera Almanza, Martha; Jimenez Antolinez, Yajaira V; Juárez Tobias, Maria Susana; López Facundo, Norma Araceli; Martínez Soria, Ruth Angélica; Miller, Kenia; Miralda, Scheybi; Morales, Roxana; Negroe Ocampo, Natalia; Osuna, Alejandra; Pascual Morales, Claudia; Pérez Fermin, Clara Krystal; Pérez Alvarado, Carlos M; Pineda, Estuardo; Andrés Portilla, Carlos; Rios López, Ligia Estefanía; Rivera, Jocelyn; Sagaón Olivares, Arely Saraí; Saguay Tacuri, Mélida Cristina; Salas Mendoza, Beatriz T; Solano Picado, Ivel; Soto Chávez, Verónica; Tejocote Romero, Isidoro; Tatay, Daniel; Teixeira Costa, Juliana; Villanueva, Erika; Villegas Pacheco, Marielba; McKay, Virginia R.
Afiliación
  • Agulnik A; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gonzalez Ruiz A; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Muniz-Talavera H; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Carrillo AK; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Cárdenas A; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Puerto-Torres MF; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Garza M; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Conde T; Casa de la Amistad, Mexico City, Mexico.
  • Soberanis Vasquez DJ; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Méndez Aceituno A; Pediatric Intensive Care Unit, Unidad Nacional de Oncología Pediátrica (UNOP), Guatemala City, Guatemala.
  • Acuña Aguirre C; Pediatric Critical Care, Hospital Dr Luis Calvo Mackenna, Santiago, Chile.
  • Alfonso Y; Pediatric Hemato-oncology, Hospital St Damien, Port-Au-Prince, Haiti.
  • Álvarez Arellano SY; Pediatric Hemato-Oncology, Benemérito Hospital General con Especialidades "Juan María de Salvatierra", La Paz, Mexico.
  • Argüello Vargas D; Pediatric Hemato-Oncology, Hospital Nacional de Niños, San Jose, Costa Rica.
  • Batista R; Pediatric Hemato-Oncology, Hospital Jose Domingo De Obaldía, Chiriqui, Panama.
  • Blasco Arriaga EE; Pediatric Critical Care, Sociedad de Lucha Contra el Cáncer (SOLCA) Guayaquil, Guayaquil, Ecuador.
  • Chávez Rios M; Pediatric Hemato-Oncology, Hospital del Niño Poblano, Puebla, Mexico.
  • Cuencio Rodríguez ME; Pediatric Hospitalization Unit, Hospital Universitario Austral, Buenos Aires, Argentina.
  • Fing Soto EA; Pediatric Hemato-Oncology, Hospital General de Celaya, Celaya, Mexico.
  • Gómez-García W; Pediatric Hemato-Oncology, Hospital Infantil Dr Robert Reid Cabral, Santo Domingo, Dominican Republic.
  • Guillén Villatoro RH; Chief Medical Officer, Hospital de Especialidades Pediátricas, Tuxtla Gutierrez, Mexico.
  • Gutiérrez Rivera ML; Pediatric Hemato-Oncology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
  • Herrera Almanza M; Pediatric Hemato-Oncology, Hospital Infantil de Especialidades de Chihuahua, Chihuahua, Mexico.
  • Jimenez Antolinez YV; Pediatric Hemato-Oncology, Hospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
  • Juárez Tobias MS; Pediatric Hemato-Oncology, Hospital Central Dr Ignacio Morones Prieto, San Luis Potosi, Mexico.
  • López Facundo NA; Pediatric Hemato-Oncology, Instituto de Seguridad Social del Estado de México y Municipos Hospital Materno Infantil, Toluca, Mexico.
  • Martínez Soria RA; Pediatric Hospitalization Unit., Hospital General de Tijuana, Tijuana, Mexico.
  • Miller K; Pediatric Hemato-Oncology, Hospital del Niño "Jose Renan Esquivel", Panama, Panama.
  • Miralda S; Pediatric Critical Care, Hospital Escuela, Tegucigalpa, Honduras.
  • Morales R; Pediatric Hemato-Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Negroe Ocampo N; Pediatric Hemato-Oncology, Hospital General Agustin O'Horan, Mérida, Mexico.
  • Osuna A; Pediatric Hemato-Oncology, Hospital Pediátrico de Sinaloa, Culiacan, Mexico.
  • Pascual Morales C; Pediatric Hemato-Oncology, Hospital Guillermo Almenara Irigoyen, Lima, Peru.
  • Pérez Fermin CK; Pediatric Hemato-Oncology, Hospital Infantil Regional Universitario Dr Arturo Grullón, Santiago, Dominican Republic.
  • Pérez Alvarado CM; Research Unit, Centro Estatal de Cancerología Dr Miguel Dorantes Mesa, Xalapa, Mexico.
  • Pineda E; Pediatric Hemato-Oncology, Hospital de Niños Benjamín Bloom, San Salvador, El Salvador.
  • Andrés Portilla C; Pediatric Hemato-Oncology, Centro Médico Imbanaco, Cali, Colombia.
  • Rios López LE; Pediatric Hemato-Oncology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
  • Rivera J; Department of Pediatrics, Hospital Infantil Teletón de Oncología (HITO), Queretaro, Mexico.
  • Sagaón Olivares AS; Nursing Education, Hospital del Niño. Sistema integral para el Desarrollo de la Familia (DIF), Pachuca, Mexico.
  • Saguay Tacuri MC; Pediatric hemato-oncology, SOLCA Cuenca, Cuenca, Ecuador.
  • Salas Mendoza BT; Pediatric Hemato-Oncology, Hospital del Niño Manuel Ascencio Villarroel, Cochabamba, Bolivia.
  • Solano Picado I; Pediatric Hemato-Oncology, Hospital Infantil de Nicaragua, Managua, Nicaragua.
  • Soto Chávez V; Pediatric Hemato-Oncology, Hospital Civil de Guadalajara, Guadalajara, Mexico.
  • Tejocote Romero I; Pediatric Hemato-Oncology, Institutio Materno Infantil del Estado de México-IMIEM, Toluca, Mexico.
  • Tatay D; Pediatric Hemato-Oncology, Hospital del Niños de la Santísima Trinidad de Córdoba, Cordoba, Argentina.
  • Teixeira Costa J; Pediatric Hemato-Oncology, Hospital Martagão Gesteira, Salvador, Bahia, Brazil.
  • Villanueva E; Pediatric Hemato-Oncology, SOLCA Quito, Quito, Ecuador.
  • Villegas Pacheco M; Pediatric Hemato-Oncology, Centro Estatal de Oncología, Campeche, Mexico.
  • McKay VR; Bloom School of Medicine, Washington University, St Louis, Missouri, USA.
Cancer ; 128(22): 4004-4016, 2022 11 15.
Article en En | MEDLINE | ID: mdl-36161436
ABSTRACT

BACKGROUND:

Pediatric early warning systems (PEWS) aid in the early identification of deterioration in hospitalized children with cancer; however, they are under-used in resource-limited settings. The authors use the knowledge-to-action framework to describe the implementation strategy for Proyecto Escala de Valoracion de Alerta Temprana (EVAT), a multicenter quality-improvement collaborative, to scale-up PEWS in pediatric oncology centers in Latin America.

METHODS:

Proyecto EVAT mentored participating centers through an adaptable implementation strategy to (1) monitor clinical deterioration in children with cancer, (2) contextually adapt PEWS, (3) assess barriers to using PEWS, (4) pilot and implement PEWS, (5) monitor the use of PEWS, (6) evaluate outcomes, and (7) sustain PEWS. The implementation outcomes assessed included the quality of PEWS use, the time required for implementation, and global program impact.

RESULTS:

From April 2017 to October 2021, 36 diverse Proyecto EVAT hospitals from 13 countries in Latin America collectively managing more than 4100 annual new pediatric cancer diagnoses successfully implemented PEWS. The time to complete all program phases varied among centers, averaging 7 months (range, 3-13 months) from PEWS pilot to implementation completion. All centers ultimately implemented PEWS and maintained high-quality PEWS use for up to 18 months after implementation. Across the 36 centers, more than 11,100 clinicians were trained in PEWS, and more than 41,000 pediatric hospital admissions had PEWS used in their care.

CONCLUSIONS:

Evidence-based interventions like PEWS can be successfully scaled-up regionally basis using a systematic approach that includes a collaborative network, an adaptable implementation strategy, and regional mentorship. Lessons learned can guide future programs to promote the widespread adoption of effective interventions and reduce global disparities in childhood cancer outcomes. LAY

SUMMARY:

Pediatric early warning systems (PEWS) are clinical tools used to identify deterioration in hospitalized children with cancer; however, implementation challenges limit their use in resource-limited settings. Proyecto EVAT is a multicenter quality-improvement collaborative to implement PEWS in 36 pediatric oncology centers in Latin America. This is the first multicenter, multinational study reporting a successful implementation strategy (Proyecto EVAT) to regionally scale-up PEWS. The lessons learned from Proyecto EVAT can inform future programs to promote the adoption of clinical interventions to globally improve childhood cancer outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología Médica / Neoplasias Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología Médica / Neoplasias Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos